US Stocks
/
Design Therapeutics, Inc. Share Price
Design Therapeutics, Inc. Share Price

Design Therapeutics, Inc. Share Price

NASDAQ: DSGN | Small Cap
$11.65
+$0.17 (1.48%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Design Therapeutics, Inc. Stock Performance

Open
$11.48
Prev. Close
$11.48
Circuit Range
N/A
Day Range
$11.48 - $11.84
Year Range
$5.30 - $17.20
Volume
19,604
Average Traded
$11.65

Design Therapeutics, Inc. Share Price Today

As of 10 October 2026, Design Therapeutics, Inc.'s share price is $11.65. The stock opened at $11.48, compared to its previous close of $11.48. During today's trading session, Design Therapeutics, Inc.'s share price traded between $11.48 and $11.84, with an average price of $11.66. Over the past 52 weeks, the stock has recorded a high of $17.20 and a low of $5.30. In terms of performance, Design Therapeutics, Inc.'s share price has declined by 14.27% over the last six months and is up 79.03% on a year-on-year basis.

Design Therapeutics, Inc. Share Price Chart

$11.48$11.84
L
Show Current Price
H

Design Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$668.18M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.13
Revenue (TTM)
$0.00
Return On Equity (TTM)
-35.07%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-18.65%

Design Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.00-$16.00-$17.64-$20.17
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A5.88%-10.25%-14.34%

Design Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$63.31-$66.86-$49.59-$69.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.61%25.83%-40.73%

About Design Therapeutics, Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Design Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$12.36
$11.64
-7.47%
Sep 2026
$14.64
$12.58
-17.45%
Aug 2026
$11.92
$15.24
+25.28%
Jul 2026
$14.37
$12.16
-15.75%
Jun 2026
$10.27
$14.44
+37.52%
May 2026
$13.36
$10.50
-22.77%
Apr 2026
$10.87
$13.60
+27.89%
Mar 2026
$10.13
$10.63
+2.41%
Feb 2026
$10.60
$10.38
+1.81%
Jan 2026
$9.27
$10.20
+8.69%
Dec 2025
$9.21
$9.38
+0.11%
Nov 2025
$6.38
$9.37
+43.93%

DSGN Share Price FAQs

What is Design Therapeutics, Inc. share price today?

chevron-up
Design Therapeutics, Inc. share price today is $11.65 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Design Therapeutics, Inc. stock?

chevron-up
The 52 week high of Design Therapeutics, Inc. stock is $17.20, while the 52 week low is $5.30 as of 10 Oct '26.

What is DSGN's market capitalisation today?

chevron-up
DSGN market capitalisation is $668.18M as of October 10, 2026, at 4:41 am IST.

What is DSGN's net income for the last quarter?

chevron-up
DSGN's net income for the last quarter is -20.17B USD.

What is the 5 year returns of DSGN?

chevron-up
The 5 year returns of DSGN is -25.67% as on 10 Oct '26.

What is the high & low stock price of DSGN today?

chevron-up
DSGN stock price hit a high of $11.84 and low of $11.48 as of 10 Oct '26.

Can I buy DSGN shares in India?

chevron-up
Yes. You can buy DSGN in India by opening an international trading account.